Magnesium plus interactive agent delivery

   
   

The present invention is an orally administered pharmaceutical composition that provides for the controlled release of magnesium. The composition has an interactive agent component and a magnesium component which has an enteric coating that controls the release of the magnesium until the composition is in the small intestine or colon. The other component is released in the stomach and is substantially absorbed prior to the release of the magnesium component. Normally, the interactive agent component decreases the absorption of magnesium when the two components are released simultaneously in the gastrointestinal tract.

 
Web www.patentalert.com

< Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components

< Glucagon antagonists/inverse agonists

> Pyranoindazoles and their use for the treatment of glaucoma

> Methods for identification of identical nucleic acid fragments from different nucleic acid populations

~ 00177